BioPharma Pharma QC

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...

 March 28, 2022 | News

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...

 March 25, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

 March 18, 2022 | News

Everest Medicines to further enhance its international commercial footprint

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...

 March 14, 2022 | News

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...

 March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

 March 03, 2022 | News

RosVivo signed MTA for diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...

 February 23, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

 February 18, 2022 | News

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

 February 11, 2022 | News

Singapore (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative ph...

 February 07, 2022 | News

Nanoform signs GMP manufacturing program with TargTex following formulation success

This follows a successful PoC (Proof of Concept) study where the hydrogel formulation developed by Nanoform (CESS®2 technology-based nanoparticles...

 February 07, 2022 | News

Phenomenex Celebrates 40-Years of Keeping Scientists Happy & What's to Come

On this day in 1982, Phenomenex was born. Over the last four decades what started as a small idea in a garage has grown into a global corporation with more...

 February 04, 2022 | News

Germfree launches novel mobile cleanroom technology for advanced therapies

Germfree’s biomanufacturing platform addresses current industry needs, while de-risking and future-proofing for a rapidly evolving industry. "The ind...

 February 03, 2022 | News

Yokogawa Enhances Cybersecurity and Safety for the OpreX Control and Safety System Lineup

With this certification, Yokogawa’s  CENTUM VP integrated production control system and ProSafe-RS safety instrumented system now both  con...

 January 24, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close